|1.||Seidel, Erin E: 1 article (06/2012)|
|2.||Telleria, Carlos M: 1 article (06/2012)|
|3.||Goyeneche, Alicia A: 1 article (06/2012)|
|4.||Hanssen, Robert G J M: 1 article (02/2005)|
|5.||Mulders, Titia M T: 1 article (02/2005)|
|6.||Korver, Geert H V: 1 article (02/2005)|
|7.||Verbost, Pieter M: 1 article (02/2005)|
|8.||Bouchard, P: 1 article (10/2002)|
|9.||Cameron, S: 1 article (10/2002)|
|10.||Killick, S R: 1 article (10/2002)|
02/01/2005 - "Under POP treatment, ORG 31710 induced monthly bleeding and completely reduced intermittent (or breakthrough) bleedings, albeit for a limited number of days (+/- 10 days); thereafter, the incidence of spot bleedings returned to average levels with a POP, until the next monthly ORG 31710 administration. "
10/01/2002 - "Compared with controls, less subjects in the Org 31710 group reported irregular, frequent or prolonged bleeding. "
02/01/2005 - "In clinical trials ORG 31710 appeared to be effective for inducing vaginal bleeding after single-dose administration in the luteal phase of a normal cycle and for improving vaginal bleeding patterns of subjects using the 75 microg desogestrel progestagen-only pill (POP). "
02/01/2005 - "ORG 33628 and ORG 31710 to control vaginal bleeding in progestin-only contraceptive regimens."
02/01/2005 - "ORG 31710 and ORG 33628 were used in studies aiming to control vaginal bleeding in combination with progestagen-only contraception in primates. "
|2.||Ovarian Neoplasms (Ovarian Cancer)
06/01/2012 - "In this study we investigated the molecular mediators of the anti-ovarian cancer activity of the structurally related antiprogestins RU-38486, ORG-31710 and CDB-2914. "
06/01/2012 - "Growth inhibition induced by antiprogestins RU-38486, ORG-31710, and CDB-2914 in ovarian cancer cells involves inhibition of cyclin dependent kinase 2."
|4.||Breast Neoplasms (Breast Cancer)
|2.||Mifepristone (RU 486)
|5.||Cyclin-Dependent Kinase 2
|6.||Cyclin-Dependent Kinases (cdk Proteins)
|1.||Contraception (Birth Control)